Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3743-3746

  Kim, Duk Hwan ^a   Kim, Jin Seuk ^a   Ji, Yong Ick ^a   Shim, Young Mog ^b   Kim, Hojoong ^b   Han, Joungho ^b   Park, Joobae ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P14; PROTEIN P16; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CIGARETTE SMOKING; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SURVIVAL TIME; TUMOR SUPPRESSOR GENE;

ADULT; AGING; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; PROGNOSIS; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; SMOKING; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0038418287     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eguchi, K., Kanai, Y., Kobayashi, K., and Hirohashi, S. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res., 57: 4913-4915, 1997.
2. INK4A in primary rat lung tumors. Mol. Cell. Biol., 17: 1366-1374, 1997.
3. INK4A is an early event in lung cancer and a potential marker for early diagnosis. Proc. Natl. Acad. Sci. USA, 95, 11891-11896, 1998.
4. INK4A and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res., 61: 3419-3424, 2001.
5. Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S., Smith, T. M., Moots, P. P., Lechner, J. F., Stidley, C. A., and Crowell, R. E. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res., 62: 2370-2377, 2002.
6. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
7. Robertson, K. D., and Jones, P. A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and downregulated by wild-type p53. Mol. Cell. Biol., 18: 6457-6473, 1998.
8. Lo, K. W. Kwong, J. K., Hui, A. B-Y., Chan, S. Y-Y., To, K-F., Chan, A. S-C., Chow, L. S-N., Teo, P. M. L., Johnson, P. J., and Huang, D. P. High frequency of promoter hypermethylaiton of RASSF1A in nasophryngenal carcinoma. Cancer Res., 61, 3877-3881, 2001.
9. INK4a methylation and p53 mutational status. Cancer Res., 60: 129-133, 2000.
10. Zöchbauer-Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar A. F., and Minna, J. D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res., 61: 249-255 2001.
11. Kok, K., Osinga, J., Carritt, B., Davis, M. B., van der Hout, A. H. van der Veen, A. Y., Landsvater, R. M., de Leij, L. F., Berendsen, H. H., and Postmus, P. E. Deletion of a DNA sequences at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330: 578-581, 1987.
12. Naylor, S. L. Johnson, B. E., Minna, J. D., and Sakaguchi, A. Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (Lond.), 329: 451-454, 1987.
13. Wistuba, I. I., Behrens, C., Virmani, A. K., Mele, G., Milchgrub, S., Girard, L., Fondon, J. W., III. Garner, H. R., McKay, B., Latif, F., Lerman, M. I., Lam, S., Gadzar, A. F., and Minna, J. D. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res., 60: 1949-1960, 2000.
14. Dammann, R., Li, C., Yoon, J. H., Chin, P. L., Bates, S., and Pfeifer, G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat. Genet., 25: 315-319, 2000.
15. Burbee, D. G., Forgacs, E., Zöchbauer-Müller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Scott, B., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gadzar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. (Bethesda), 93: 691-699, 2001.
16. Agathanggelou, A., Honorio, S., Macartney, D. P., Martinez, A., Dallol, A., Rader, J., Fullwood, P., Chauhan, A., Walker, R., Shaw, J. A., Hosoe, S., Lerman, M., Minna, J. D., Maher, E. R., and Latif, F. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung breast and ovarian tumors. Oncogene. 20: 1509-1518, 2001.
17. Tomizawa, Y., Kohno, T., Kondo, H., Otsuka, A., Nishioka, M., Niki, T., Yamada, T., Maeshima, A., Yoshimura, K., Saito, R., Minna, J. D., and Yokota, J. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin. Cancer Res., 8, 2362-2368, 2002.
18. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
19. Vertino, P. M., Yen, R. W., Gao, J., and Baylin, S. B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-) methyltransferase. Mol. Cell. Biol., 16: 4555-4565, 1996.
20. Belinsky, S. A., Nikula, K. J., Baylin, S. B., and Issa, J-P. J. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA, 93: 4045-4050, 1996.